基于尿TIMP2与IGFBP7的急性肾损伤风险预测模型构建及其在危重症患者中的早期预测价值
该前瞻性观察研究纳入2017年11月至2020年4月入住苏北人民医院ICU的206例急性呼吸衰竭或循环障碍患者,入科24小时内检测尿TIMP2×IGFBP7并收集临床资料,以入组后12小时内发生2级或3级AKI为终点。54例(26.2%)发生2级或3级AKI。多因素Logistic回归显示BMI(OR=1.23,95%CI 1.10-1.37,P=0.000)、入组前SCr(OR=1.01,95%CI 1.00-1.02,P=0.042)、使用肾毒性药物(OR=2.84,95%CI 1.34-6.03,P=0.007)和尿TIMP2×IGFBP7(OR=2.19,95%CI 1.56-3.08,P=0.000)为独立危险因素,并据此构建列线图模型。尿TIMP2×IGFBP7单独预测的AUC为0.74(95%CI 0.66-0.83),最佳截断值1.40(μg/L)²/1000(敏感度66.7%,特异度85.0%);包含该标志物的模型AUC为0.85(95%CI 0.79-0.91),显著优于不含该标志物的模型0.77(95%CI 0.70-0.84)(P=0.005),NRI=0.29(95%CI 0.08-0.50,P=0.008),IDI=0.13(95%CI 0.07-0.19,P<0.001)。作者认为该模型具有较高临床价值,有望用于早期预测危重症患者AKI的发生。
要点
- ICU入科24小时内尿TIMP2×IGFBP7每升高1个单位,12小时内发生2级或3级AKI的OR=2.19(95%CI 1.56-3.08,P=0.000)。
- 尿TIMP2×IGFBP7单独预测12小时内2级或3级AKI的AUC为0.74(95%CI 0.66-0.83),最佳截断值1.40(μg/L)²/1000,敏感度66.7%、特异度85.0%。
- 含尿TIMP2×IGFBP7的列线图模型AUC为0.85(95%CI 0.79-0.91),优于不含该标志物的模型0.77(95%CI 0.70-0.84),P=0.005。
- BMI(OR=1.23,95%CI 1.10-1.37,P=0.000)、入组前SCr(OR=1.01,95%CI 1.00-1.02,P=0.042)、使用肾毒性药物(OR=2.84,95%CI 1.34-6.03,P=0.007)为独立危险因素。
- 206例中54例(26.2%)在入组后12小时内发生2级或3级AKI,AKI组BMI、入组前SCr、尿TIMP2×IGFBP7及使用血管活性药物比例更高,入组前肾毒性药物暴露更常见。
适用人群与场景
- 2017年11月至2020年4月入住苏北人民医院ICU的急性呼吸衰竭或循环障碍患者,于入ICU 24小时内入组。
诊断标准与关键阈值
- 以入组后12小时内发生2级或3级急性肾损伤(AKI)为分组与预测终点,分为非AKI组与AKI组。
- 尿TIMP2×IGFBP7预测12小时内2级或3级AKI的最佳截断值为1.40(μg/L)²/1000。
研究设计与关键结果
- 前瞻性观察研究,最终纳入206例,54例(26.2%)在入组后12小时内发生2级或3级AKI,152例(73.8%)未发生。
- 与非AKI组相比,AKI组BMI、入组前SCr、尿TIMP2×IGFBP7及使用血管活性药物比例更高,入组前使用肾毒性药物(AKI额外暴露)更常见。
- 多因素Logistic回归:BMI(OR=1.23,95%CI 1.10-1.37,P=0.000)、入组前SCr(OR=1.01,95%CI 1.00-1.02,P=0.042)、使用肾毒性药物(OR=2.84,95%CI 1.34-6.03,P=0.007)、尿TIMP2×IGFBP7(OR=2.19,95%CI 1.56-3.08,P=0.000)为危重症患者12小时内发生2级或3级AKI的独立危险因素。
- 基于上述独立危险因素构建AKI风险预测列线图模型,Bootstrap验证显示模型内部验证区分度与校准度良好。
- 尿TIMP2×IGFBP7单独预测12小时内2级或3级AKI的AUC为0.74(95%CI 0.66-0.83),最佳截断值1.40(μg/L)²/1000,敏感度66.7%,特异度85.0%。
- 含尿TIMP2×IGFBP7的模型预测性能显著优于不含该标志物的模型:AUC 0.85(95%CI 0.79-0.91)vs. 0.77(95%CI 0.70-0.84),P=0.005;NRI=0.29(95%CI 0.08-0.50,P=0.008);IDI=0.13(95%CI 0.07-0.19,P<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于尿TIMP2×IGFBP7的AKI风险预测模型具有较高临床价值,有望用于早期预测危重症患者AKI的发生。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To establish a risk predictive model nomogram of acute kidney injury (AKI) in critically ill patients by combining urinary tissue inhibitor of metalloproteinase 2 (TIMP2) and insulin-like growth factor-binding protein 7 (IGFBP7), and to verify the predictive value of the model.
METHODS: A prospective observational study was conducted. The patients with acute respiratory failure or circulatory disorder admitted to the intensive care unit (ICU) of Northern Jiangsu People's Hospital from November 2017 to April 2020 were enrolled. The patients were enrolled within 24 hours of ICU admission, and their general conditions and relevant laboratory test indicators were collected. At the same time, urine was collected to determine the levels of biomarkers TIMP2 and IGFBP7, and TIMP2×IGFBP7 was calculated. Patients were divided into non-AKI and AKI groups according to whether grade 2 or 3 AKI occurred within 12 hours after enrollment. The general clinical data and urinary TIMP2×IGFBP7 levels of patients between the two groups were compared. The indicators with P < 0.1 in univariate analysis were included in the multivariate Logistic regression analysis to obtain the independent risk factors for grade 2 or 3 AKI within 12 hours in critical patients. An AKI risk predictive model nomogram was established, and the application value of the model was evaluated.
RESULTS: A total of 206 patients were finally enrolled, of whom 54 (26.2%) developed grade 2 or 3 AKI within 12 hours of enrollment, and 152 (73.8%) did not. Compared with the non-AKI group, the patients in the AKI group had higher body mass index (BMI), pre-enrollment serum creatinine (SCr), urinary TIMP2×IGFBP7 and proportion of using vasoactive drugs, and additional exposure to AKI (use of nephrotoxic drugs before enrollment) was more common. Multivariate Logistic regression analysis showed that BMI [odds ratio (OR) = 1.23, 95% confidence interval (95%CI) was 1.10-1.37, P = 0.000], pre-enrollment SCr (OR = 1.01, 95%CI was 1.00-1.02, P = 0.042), use of nephrotoxic drugs (OR = 2.84, 95%CI was 1.34-6.03, P = 0.007) and urinary TIMP2×IGFBP7 (OR = 2.19, 95%CI was 1.56-3.08, P = 0.000) was an independent risk factor for the occurrence of grade 2 or 3 AKI in critical patients. An AKI risk predictive model nomogram was constructed based on the independent risk factors of AKI. Bootstrap validation results showed that the model had good discrimination and calibration in internal validation. Receiver operator characteristic curve (ROC curve) analysis showed that the area under the ROC curve (AUC) of urinary TIMP2×IGFBP7 alone in predicting grade 2 or 3 AKI within 12 hours in critical patients was 0.74 (95%CI was 0.66-0.83), the optimal cut-off value was 1.40 (μg/L) 2/1 000 (sensitivity was 66.7%, specificity was 85.0%), and the predictive performance of the model incorporating urinary TIMP2×IGFBP7 was significantly better than that of the model without urinary TIMP2×IGFBP7 [AUC (95%CI): 0.85 (0.79-0.91) vs. 0.77 (0.70-0.84), P = 0.005], net reclassification index (NRI) was 0.29 (95%CI was 0.08-0.50, P = 0.008), integrated discrimination improvement (IDI) was 0.13 (95%CI was 0.07-0.19, P < 0.001).
CONCLUSIONS: The AKI risk predictive model based on urinary TIMP2×IGFBP7 has high clinical value and is expected to be used to early predict the occurrence of AKI in critically ill patients.
参考来源
- Wang H, Mou H, Xu X, et al. [Construction of a risk predictive model of acute kidney injury based on urinary tissue inhibitor of metalloproteinase 2 and insulin-like growth factor-binding protein 7 and its early predictive value in critically ill patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2024. PMID: 38813633. doi:10.3760/cma.j.cn121430-20230902-00738
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。